跳至主要内容
临床试验/JPRN-UMIN000005865
JPRN-UMIN000005865已完成4 期

Study for renal outcomes with different combination therapies including Telmisartan in patients with type 2 diabetes and hypertension - Study for the effect of telmisartan on renal benefits in patients with type 2 diabetes and hypertension

Hokkaido University Hospital0 个研究点目标入组 105 人开始时间: 2011年6月28日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) severe hepatic dysfunction, renal dysfunction, heart failure, 2) history of anaphylaxis of Telmisartan, Hydrochlorothiazide or Amlodipine , 3) pregnancy, 4) patients who are inadequate to enter this study due to the other reasons by physician's judgments

研究者

相似试验

Study for renal outcomes with different combination... | 临床试验